|
James Mathews, PhD, has over 20 years of experience in directing investigations of the metabolism and disposition of drugs, commodity chemicals, and crop protection products for industry, regulatory agencies, and the National Institutes of Health. In 1985, Dr. Mathews joined RTI as a study director responsible for ADME investigations of xenobiotics in mammals. While at RTI, he oversaw the development of a full-service DMPK department, conducting investigations focused from the molecular and biomolecular level through cellular and subcellular investigations, and studies with isolated organs and in vivo models. He is currently the director of RTI's Drug Metabolism and Pharmacokinetics department. In addition to authoring over 35 peer-reviewed articles, Dr. Mathews is a diplomate of the American Board of Toxicology and a member of the organizing committees and session chair for meetings of the International Society for the Study of Xenobiotics and the Gordon Conference on Drug Metabolism. | 